Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2023-09-06 00:00:00 ET · period of report 2023-09-01 · accession 0001610717-23-000261 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-09-06 | 2023-09-01 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $0.7721 | +30.0K | 387.4K | +8% | +$23.2K |
| D | 2023-09-06 | 2023-09-01 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | S - Sale+OE | $35.05 | -30.0K | 357.4K | -8% | -$1.05M |
| DMI | 2023-09-06 | 2023-09-01 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | S - Sale+OE | $35.04 | -10.0K | 35.4K | -22% | -$350.4K |
| DM | 2023-09-06 | 2023-09-01 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $0.00 | -30.0K | 205.5K | -13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-01 | M | A | 17,993 | $0.54 | 375,379 | D Trust | — | — | (F2) Includes 190,000 restricted stock units. (F3) Includes 1,514 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2023. (F7) Held by Jonathan Henry Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011. |
| 2 | Common | Common Stock | 2023-09-01 | M | A | 12,007 | $1.12 | 387,386 | D Trust | — | — | (F2) Includes 190,000 restricted stock units. (F3) Includes 1,514 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2023. (F10) Held by Rebecca Eve Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011. |
| 3 | Common | Common Stock | 2023-09-01 | S | D | 30,000 | $35.05 | 357,386 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $35.00 to $35.24. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Includes 190,000 restricted stock units. (F3) Includes 1,514 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2023. |
| 4 | Common | Common Stock | 2023-09-01 | S | D | 5,000 | $35.04 | 35,424 | I | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $35.00 to $35.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2023-09-01 | S | D | 5,000 | $35.04 | 35,424 | I | — | — | (F9) This transaction was executed in multiple trades at prices ranging from $35.00 to $35.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Derivative | Stock Option (Right to Buy) | 2023-09-01 | M | D | 12,007 | $0.00 | 46,479 | D | $1.12 · 2022-03-29 to 2028-04-19 | 12,007 Common Stock | |
| 7 | Derivative | Stock Option (Right to Buy) | 2023-09-01 | M | D | 17,993 | $0.00 | 205,503 | D | $0.54 · 2022-03-01 to 2028-02-11 | 17,993 Common Stock |